The knockdown of AKT by its specific shRNA could suppress IL-32 levels (Figure 3C), while activating AKT via SC79 promoted its expression (Figure 3D), confirming that the activation of AKT was responsible for the upregulation of IL-32 in HCC cells. Here, AKT1 is linked to hepatocellular carcinoma.